Biomerica (BMRA) Shares Outstanding (2010 - 2026)
Biomerica (BMRA) reported Shares Outstanding (Entity) of $3.0 million for Q1 2026, up 19.0% on a YoY basis from $2.5 million in Q1 2025, and up 2.76% sequentially from $2.9 million in Q4 2025.
Biomerica (BMRA) Shares Outstanding (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Shares Outstanding (Entity) data on file, last reported at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Entity) rose 19.0% year-over-year to $3.0 million; the trailing twelve-month figure through Feb 2026 stood at $3.0 million (up 19.0% YoY), and the FY2025 full-year result was $2.5 million, up 21.09% from the prior year.
- Shares Outstanding (Entity) advanced to $3.0 million in Q1 2026, from $2.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $3.0 million in Q1 2026 to a low of $1.6 million in Q1 2022.
- A 5-year average of $2.2 million and a median of $2.1 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2024 and surged 33.89% in 2025, its largest moves.
- Tracing BMRA's Shares Outstanding (Entity) over 5 years: stood at $1.7 million in 2022, then climbed by 24.8% to $2.1 million in 2023, then gained by 9.01% to $2.3 million in 2024, then gained by 28.61% to $2.9 million in 2025, then rose by 2.76% to $3.0 million in 2026.
- Business Quant data shows BMRA's Shares Outstanding (Entity) at $3.0 million in Q1 2026, $2.9 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 3.01 Mn |
| Nov 30, 2025 | 2.91 Mn |
| Aug 31, 2025 | 2.64 Mn |
| May 31, 2025 | 2.30 Mn |
| Feb 28, 2025 | 2.40 Mn |
| Nov 30, 2024 | 2.14 Mn |
| Aug 31, 2024 | 2.10 Mn |
| May 31, 2024 | 2.10 Mn |
| Feb 29, 2024 | 2.10 Mn |
| Nov 30, 2023 | 2.10 Mn |
| Aug 31, 2023 | 2.10 Mn |
| May 31, 2023 | 1.77 Mn |
| Feb 28, 2023 | 1.69 Mn |
| Nov 30, 2022 | 1.68 Mn |
| Aug 31, 2022 | 1.64 Mn |
| May 31, 2022 | 1.58 Mn |
| Feb 28, 2022 | 1.60 Mn |
| Nov 30, 2021 | 1.57 Mn |
| Aug 31, 2021 | 1.55 Mn |
| May 31, 2021 | 1.49 Mn |